| Literature DB >> 25617175 |
Andrew A Dwyer1, Taneli Raivio2, Nelly Pitteloud3.
Abstract
Congenital hypogonadotrophic hypogonadism (CHH) is a rare form of infertility caused by deficient secretion or action of gonadotrophin-releasing hormone. There is no consensus regarding the optimal approach to fertility treatment in CHH men. In most cases, appropriate hormonal treatment with human chorionic gonadotrophin with or without follicle stimulating hormone will induce testicular development, spermatogenesis and fertility. Recent studies have examined sequential treatment with FSH pre-treatment to optimize fertility outcomes in severely affected CHH patients. This paper reviews historical and recent literature to summarize the current evidence on therapeutic approaches for CHH men seeking fertility.Entities:
Keywords: GnRH deficiency; Kallmann syndrome; fertility outcomes; fertility treatment; gonadotrophin therapy; hypogonadotrophic hypogonadism; male fertility
Mesh:
Substances:
Year: 2014 PMID: 25617175 DOI: 10.1016/j.beem.2014.10.005
Source DB: PubMed Journal: Best Pract Res Clin Endocrinol Metab ISSN: 1521-690X Impact factor: 4.690